15 - Role of the cortex in the regulation of anxiety states  pp. 168-179

Role of the cortex in the regulation of anxiety states

By Noelia V. Weisstaub, Caitlin McOmish, James Hanks and Jay A. Gingrich

Image View Previous Chapter Next Chapter



Defining fear and anxiety

In evolutionary terms, anxiety is considered to be a conserved behavioral response to a warning signal or a threat (Fuchs & Flugge 2004). This behavior predisposes the individual to recognize potential dangers and to prepare to deal with the threat, allowing the individual to take measures to reduce exposure to danger. In this sense, an anxious state is similar to fear, differentiating itself only in that the latter manifests as an acute response to an immediate threat (Fuchs & Flugge 2004). Both, however, serve the purpose of decreasing an individual's exposure to danger. Thus, under most circumstances, anxiety is an adaptive response to chronic danger and often engages coping mechanisms that help the organism continue with behaviors necessary for survival while minimizing its exposure to danger. This response is generally mild and is associated with recruitment of several physiological systems: motor, sensory, endocrine, immune, cardiovascular, and neuronal.

Pathological anxiety, however, is characterized by a disproportionate response to a mild or non-existent threat (Lesch et al. 2003). In humans, the various anxiety disorders classified by the Diagnostic and Statistical Manual (DSM) all have a common underlying core of pathological processes, including a persistent and increased response to potential threat or a reduced threshold for treating a situation as threatening (Stein & Bienvenu 2004).

Amargos-Bosch M. , Artigas F. , & Adell A. (2005). Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. European Journal of Pharmacology, 516, 235–238.
Amargos-Bosch M. , Bortolozzi A. , Puig M. V. , et al. (2004). Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex, 14, 281–299.
Amat J. , Baratta M. V. , Paul E. , et al. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience, 8, 365–371.
Amat J. , Paul E. , Watkins L. R. , & Maier S. F. (2008). Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control. Neuroscience, 154, 1178–1186.
Amat J. , Paul E. , Zarza C. , Watkins L. R. , & Maier S. F. (2006). Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex. Journal of Neuroscience, 26, 13264–13272.
Ansorge M. S. , Hen R. , & Gingrich J. A. (2007). Neurodevelopmental origins of depressive disorders. Current Opinion in Pharmacology, 7, 8–17.
Ansorge M. S. , Zhou M. , Lira A. , Hen R. , & Gingrich J. A. (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science, 306, 879–881.
Araneda R. , & Andrade R. (1991). 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience, 40, 399–412.
Arango V. , Underwood M. D. , & Mann J. J. (1997). Postmortem findings in suicide victims. Implications for in vivo imaging studies. Annals of the New York Academy of Sciences, 836, 269–287.
Arce E. , Simmons A. N. , Lovero K. L. , Stein M. B. , & Paulus M. P. (2008). Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berlin), 196, 661–672.
Azmitia E. C. , Gannon P. J. , Kheck N. M. , & Whitaker-Azmitia P. M. (1996). Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology, 14, 35–46.
Baratta M. V. , Christianson J. P. , Gomez D. M. , et al. (2007). Controllable versus uncontrollable stressors bi-directionally modulate conditioned but not innate fear. Neuroscience, 146, 1495–1503.
Beique J. C. , Imad M. , Mladenovic L. , Gingrich J. A. , & Andrade R. (2007). Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proceedingss of the National Academy of Sciences of the USA, 104, 9870–9875.
Bennett A. J. , Lesch K. P. , Heils A. , et al. (2002). Early experience and serotonin transporter gene variation interact to influence primate CNS function. Molecular Psychiatry, 7, 118–122.
Bevilaqua L. R. , Bonini J. S. , Rossato J. I. , et al. (2006). The entorhinal cortex plays a role in extinction. Neurobiology of Learning and Memory, 85, 192–197.
Bhagwagar Z. , Hinz R. , Taylor M. , et al. (2006). Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C]MDL 100,907. American Journal of Psychiatry, 163, 1580–1587.
Bishop S. , Duncan J. , Brett M. , & Lawrence A. D. (2004). Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nature Neuroscience, 7, 184–188.
Bortolozzi A. , Amargos-Bosch M. , et al. (2003) In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. European Journal of Neuroscience, 18, 1235–1246.
Bortolozzi A. , Diaz-Mataix L. , Scorza M. C. , Celada P. , & Artigas F. (2005). The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. Journal of Neurochemistry, 95, 1597–1607.
Bruening S. , Oh E. , Hetzenauer A. , et al. (2006). The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system. Journal of Neurochemistry, 99, 892–899.
Burgos-Robles A. , Vidal-Gonzalez I. , Santini E. , & Quirk G. J. (2007). Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron, 53, 871–880.
Cai X. , Gu Z. , Zhong P. , Ren Y. , & Yan Z. (2002). Serotonin 5-HT1A receptors regulate AMPA receptor channels through inhibiting Ca2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. Journal of Biological Chemistry, 277, 36553–36562.
Cameron O. G. , Huang G. C. , Nichols T. , et al. (2007) Reduced gamma-aminobutyric acidA-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Archives of General Psychiatry, 64, 793–800.
Carroll J. C. , Boyce-Rustay J. M. , Millstein R. , et al. (2007). Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behavior Genetics, 37, 214–222.
Caspi A. , Sugden K ,. Moffitt T. E. , et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–389.
Celada P. , Puig M. , Amargos-Bosch M. , Adell A. , & Artigas F. (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of Psychiatry and Neuroscience, 29, 252–265.
Celada P. , Puig M. V. , Casanovas J. M. , Guillazo G. , & Artigas F. (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABAA, and glutamate receptors. Journal of Neuroscience, 21, 9917–9929.
Celada P. , Puig M. V. , Diaz-Mataix L. , & Artigas F. (2008). The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biological Psychiatry, 64, 392–400.
Champoux M. , Bennett A. , Shannon C. , et al. (2002). Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Molecular Psychiatry, 7, 1058–1063.
Cheng L. L. , Wang S. J. , & Gean P. W. (1998). Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. European Journal of Neuroscience, 10, 2163–2172.
Corcoran K. A. , & Quirk G. J. (2007). Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. Journal of Neuroscience, 27, 840–844.
Cornea-Hebert V. , Riad M. , Wu C. , Singh S. K. , & Descarries L. (1999). Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. Journal of Computational Neurology, 409, 187–209.
Crayton J. W. , Joshi I. , Gulati A. , Arora R. C. , & Wolf W. A. (1996). Effect of corticosterone on serotonin and catecholamine receptors and uptake sites in rat frontal cortex. Brain Research, 728, 260–262.
Critchley H. D. , Wiens S. , Rotshtein P. , Ohman A. , & Dolan R. J. (2004). Neural systems supporting interoceptive awareness. Nature Neuroscience, 7, 189–195.
Davis M. (2004). Functional neuroanatomy of anxiety and fear. In D. S. Charney & E. J. Nestler , eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Davis M. (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. American Psychologist, 61, 741–756.
Egner T. (2008). Multiple conflict-driven control mechanisms in the human brain. Trends in Cognitive Science, 12, 374–380.
Etkin A. , Egner T. , Peraza D. M. , Kandel E. R. , & Hirsch J. (2006). Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron, 51, 871–882.
Forster G. L. , Feng N. , Watt M. J. , et al. (2006). Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience, 141, 1047–1055.
Fox M. A. , Andrews A. M. , Wendland J. R. , et al. (2007). A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berlin), 195, 147–166.
Frokjaer V. G. , Mortensen E. L. , Nielsen F. Å. , et al. (2008). Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry, 63, 569–576.
Fuchs E. , & Flugge G. (2004). Animal models of anxiety disorders. In D. S. Charney & E. J. Nestler , eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Gilmartin M. R. , & McEchron M. D. (2005). Single neurons in the medial prefrontal cortex of the rat exhibit tonic and phasic coding during trace fear conditioning. Behavioral Neuroscience, 119, 1496–1510.
Golimbet V. E. , Alfimova M. V. , & Mitiushina N. G. (2004) [Polymorphism of the serotonin 2A receptor gene (5HTR2A) and personality traits]. Molecular Biology (Mosk), 38, 404–412.
Grahn R. E. , Will M. J. , Hammack S. E. , et al. (1999). Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Research, 826, 35–43.
Griebel G. , Perrault G. , & Sanger D. J. (1997). A comparative study of the effects of selective and nonselective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology, 36, 793–802.
Gross C. , Santarelli L. , Brunner D. , Zhuang X. , & Hen R. (2000). Altered fear circuits in 5-HT1A receptor KO mice. Biological Psychiatry, 48, 1157–1163.
Hariri A. R. , Mattay V. S. , Tessitore A. , et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297, 400–403.
Hariri A. R. , Mattay V. S. , Tessitore A. , Fera F. , & Weinberger D. R. (2003). Neocortical modulation of the amygdala response to fearful stimuli. Biological Psychiatry, 53, 494–501.
Higley J. D. , Suomi S. J. , & Linnoila M. (1991). CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berlin), 103, 551–556.
Holmes A. (2008). Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neuroscience and Biobehavioral Reviews, 32, 1293–1314.
Holmes A. , Lit Q. , Murphy D. L. , Gold E. , & Crawley J. N. (2003a). Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes, Brain, and Behavior, 2, 365–380.
Holmes A. , Murphy D. L. , & Crawley J. N. (2003b). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry, 54, 953–959.
Holmes A. , Yang R. J. , Murphy D. L. , & Crawley J. N. (2002). Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology, 27, 914–923.
Hoyer D. , & Martin G. R. (1996). Classification and nomenclature of 5-HT receptors: a comment on current issues. Behavioural Brain Research, 73, 263–268.
Hoyer D. , Clarke D. E. , Fozard J. R. , et al. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews, 46, 157–203.
Humphrey P. P. , Hartig P. , & Hoyer D. (1993). A proposed new nomenclature for 5-HT receptors. Trends in Pharmacological Sciences, 14, 233–236.
Jacobs B. L. , & Azmitia E. C. (1992). Structure and function of the brain serotonin system. Physiological Reviews, 72, 165–229.
Jakab R. L. , & Goldman-Rakic P. S. (1998). 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proceedings of the National Academy of Sciences of the USA, 95, 735–740.
Kalueff A. V. , Fox M. A. , Gallagher P. S. , & Murphy D. L. (2007). Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain, and Behavior, 6, 389–400.
Klemenhagen K. C. , Gordon J. A. , David D. J. , Hen R. , & Gross C. T. (2006). Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology, 31, 101–111.
Koyama S. , Kubo C. , Rhee J. S. , & Akaike N. (1999). Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. Journal of Physiology, 518, 525–538.
Koyama S. , Matsumoto N. , Murakami N. , et al. (2002). Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sciences, 72, 375–387.
Krysiak R. , Obuchowicz E. , & Herman Z. S. (2000) Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides, 34, 148–157.
Lambe E. K. , & Aghajanian G. K. (2006). Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology, 31, 1682–1689.
Laviolette S. R. , Lipski W. J. , & Grace A. A. (2005). A subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input. Journal of Neuroscience, 25, 6066–6075.
Lesch K. P. , Zeng Y. , Reif A. , & Gutknecht L. (2003). Anxiety-related traits in mice with modified genes of the serotonergic pathway. European Journal of Pharmacology, 480, 185–204.
Li X. , Inoue T. , Abekawa T. , Weng S. , et al. (2006). 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. European Journal of Pharmacology, 532, 74–80.
Lira A ,. Zhou M. , Castanon N. , et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biological Psychiatry, 54, 960–971.
Maier S. F. , & Watkins L. R. (2005). Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews, 29, 829–841.
Marek G. J. , & Aghajanian G. K. (1998). 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation. Neuroscience, 86, 485–497.
Marek G. J. , & Aghajanian G. K. (1999). 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. European Journal of Pharmacology, 367, 197–206.
Marek G. J. , Wright R. A. , Gewirtz J. C. , & Schoepp D. D. (2001). A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience, 105, 379–392.
Marschner A. , Kalisch R. , Vervliet B. , Vansteenwegen D. , & Buchel C. (2008). Dissociable roles for the hippocampus and the amygdala in human cued versus context fear conditioning. Journal of Neuroscience, 28, 9030–9036.
Martin-Ruiz R. , Puig M. V. , Celada P. , et al. (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. Journal of Neuroscience, 21, 9856–9866.
Mathew S. J. , Price R. B. , & Charney D. S. (2008). Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 89–98.
Meyer J. H. , McMain S. , Kennedy S. H. , et al. (2003). Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. American Journal of Psychiatry, 160, 90–99.
Milad M. R. , Wright C. I. , Orr S. P. , et al. (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry, 62, 446–454.
Millan M. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83–244.
Miller E. K. , & Cohen J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167–202.
Miner L. A. , Backstrom J. R. , Sanders-Bush E. , & Sesack S. R. (2003). Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience, 116, 107–117.
Monk C. S. , Telzer E. H. , Mogg K. , et al. (2008). Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Archives of General Psychiatry, 65, 568–576.
Murphy D. L. , Li Q. , Engel S. , et al. (2001). Genetic perspectives on the serotonin transporter. Brain Research Bulletin, 56, 487–494.
Nash J. R. , Sargent P. A. , Rabiner E. A. , et al. (2008). Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. British Journal of Psychiatry, 193, 229–234.
Nitschke J. B. , Sarinopoulos I. , Mackiewicz K. L. , Schaefer H. S. , & Davidson R. J. (2006). Functional neuroanatomy of aversion and its anticipation. Neuroimage, 29, 106–116.
Norton N. , & Owen M. J. (2005). HTR2A: association and expression studies in neuropsychiatric genetics. Annals of Medicine, 37, 121–129.
Papez J. W. (1995). A proposed mechanism of emotion. 1937. Journal of Neuropsychiatry and Clinical Neuroscience, 7, 103–112.
Parks C. L. , Robinson P. S. , Sibille E. , Shenk T. , & Toth M. (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the USA, 95, 10734–10739.
Paulus M. P. , & Stein M. B. (2006). An insular view of anxiety. Biological Psychiatry, 60, 383–387.
Pehek E. A. , McFarlane H. G. , Maguschak K. , Price B. , & Pluto C. P. (2001). M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Research, 888, 51–59.
Pezawas L. , Meyer-Lindenberg A. , Drabant E. M. , et al. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience, 8, 828–834.
Phelps E. A. , Delgado M. R. , Nearing K. I. , & LeDoux J. E. (2004). Extinction learning in humans: role of the amygdala and vmPFC. Neuron, 43, 897–905.
Pompeiano M. , Palacios J. M. , & Mengod G. (1992). Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. Journal of Neuroscience, 12, 440–453.
Puig M. V. , Celada P. , Diaz-Mataix L. , & Artigas F. (2003). In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cerebral Cortex, 13, 870–882.
Quirk G. J. , & Mueller D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology, 33, 56–72.
Quirk G. J. , Likhtik E. , Pelletier J. G. , & Pare D. (2003). Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. Journal of Neuroscience, 23, 8800–8807.
Quirk G. J. , Russo G. K. , Barron J. L. , & Lebron K. (2000). The role of ventromedial prefrontal cortex in the recovery of extinguished fear. Journal of Neuroscience, 20, 6225–6231.
Ramboz S. , Oosting R. , Amara D. A. , et al. (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the USA, 95, 14476–14481.
Rauch S. L. , Shin L. M. , & Phelps E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research: past, present, and future. Biological Psychiatry, 60, 376–382.
Remijnse P. L. , Nielen M. M. , van Balkom A. J. , et al. (2006). Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive–compulsive disorder. Archives of General Psychiatry, 63, 1225–1236.
Ressler K. J. , & Mayberg H. S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience, 10, 1116–1124.
Risch N. , Herrell R. , Lehner T. , et al. (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA, 301, 2462–2471.
Rosenkranz J. A. , & Grace A. A. (2002). Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. Journal of Neuroscience, 22, 324–337.
Santana N. , Bortolozzi A. , Serrats J. , Mengod G. , & Artigas F. (2004). Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex, 14, 1100–1109.
Sarinopoulos I. , Dixon G. E. , Short S. J. , Davidson R. J. , & Nitschke J. B. (2006). Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain, Behavior, and Immunity, 20, 120–132.
Serretti A. , Drago A. , & De Ronchi D. (2007). HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Current Medicinal Chemistry, 14, 2053–2069.
Stein C. , Davidowa H. , & Albrecht D. (2000). 5-HT1A receptor-mediated inhibition and 5-HT2 as well as 5-HT3 receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse, 38, 328–337.
Stein M. & Bienvenu J. (2004). Diagnostic classification of anxiety disorders: DSM-5 and beyond. In D. S. Charney & E. J. Nestler , eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Tipples J. , & Sharma D. (2000). Orienting to exogenous cues and attentional bias to affective pictures reflect separate processes. British Journal of Psychology, 91, 87–97.
Tochigi M. , Umekage T. , Kato C. , et al. (2005). Serotonin 2A receptor gene polymorphism and personality traits: no evidence for significant association. Psychiatric Genetics, 15, 67–69.
Tork I. (1990), Anatomy of the serotonergic system. Annals of the New York Academy of Sciences, 600, 9–34.
Torres G. E. , & Amara S. G. (2007). Glutamate and monoamine transporters: new visions of form and function. Current Opinion in Neurobiology, 17, 304–312.
Tsetsenis T. , Ma X. H. , Lo Iacono L. , Beck S. G. , & Gross C. (2007). Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus. Nature Neuroscience, 10, 896–902.
Unschuld P. G. , Ising M. , Erhardt A. , et al. (2007). Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 424–429.
Vollenweider F. X. , Vontobel P. , Hell D. , & Leenders K. L. (1999). 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man: a PET study with 11 Craclopride. Neuropsychopharmacology, 20, 424–433.
Vuilleumier P. (2005). How brains beware: neural mechanisms of emotional attention. Trends in Cognitive Science, 9, 585–594.
Weisstaub N. V. , Zhou M. , Lira A. , et al. (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science, 313, 536–540.
Wright C. I. , Martis B. , McMullin K. , Shin L. M. , & Rauch S. L. (2003). Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biological Psychiatry, 54, 1067–1076.
Zhao S. , Edwards J. , Carroll J. , Wiedholz L. , et al. (2006). Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience, 140, 321–334.